Pharma News 3_29 posted on March 29, 2008Breaking news from the ACC: Vytorin/Zetia gets panned - shows no benefit on the primary endpoint, though effective in reducing some markers. Doctors now wary and skeptical. Merck and Schering-Plough …Continue Reading about Pharma News 3_29 →